Massive german study to track how blood cancer patients really fare
NCT ID NCT06043011
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times
Summary
This study is a large registry that will follow nearly 3,000 people with blood cancers like chronic lymphocytic leukemia and several types of lymphoma. Researchers will collect information on treatments, how the disease progresses, and patients' quality of life over time. The goal is to understand what happens in everyday medical practice, not to test a new drug or therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Praxis für Interdisziplinäre Hämatologie und Onkologie
RECRUITINGFreiburg im Breisgau, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 3D-Printed models unlock personalized blood cancer therapies?
- Can a Two-Drug combo keep aggressive lymphoma at bay?
- Can a 'Universal' cancer target outsmart resistant blood cancers?
- Could a protein blocker quiet Leukemia's alarm system?
- Can a single shot build a cancer army inside the body?
- Can a smart immune cell with a kill switch beat tough lymphomas?